Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 03.11.2026 GMAY.LN IE000P0FL8E3 1,300,002.00 USD 52,732,039.54 40.563 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 03.11.2026 FTMO.LN IE000CY30YV9 3,125,002.00 USD 91,922,417.25 29.415 ...
-
MarineMax Reports Fiscal 2026 Fourth Quarter and Full Year Results
OLDSMAR, Fla.--(BUSINESS WIRE)--MarineMax, Inc. (NYSE: HZO) (“MarineMax” or the “Company”), a boat and yacht retailer, marina operator, and superyacht services company, today announced results for its fiscal 2026 fourth quarter and full year ended September 30, 2026. Fiscal 2026 Fourth Quarter Summary Revenue of $520.1 million Same-store sales decreased 5.7% Gross margin increased 270 basis points to 37.4% Net loss attributable to MarineMax of $13.0 million Net loss per share of $0.59; adjusted...
-
Form 10-Q for the Quarterly Period Ended September 30, 2026
DUBLIN--(BUSINESS WIRE)--Smurfit Westrock plc (the “Company”) has filed its quarterly report on Form 10-Q for the quarterly period ended September 30, 2026, with the U.S Securities and Exchange Commission (the “SEC”). The Form 10-Q is available to view on the SEC’s website at: https://www.sec.gov and the Company’s website at: https://investors.smurfitwestrock.com/financials/sec-filings/default.aspx....
-
Cencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it is realigning its corporate and reporting structure to strengthen execution and visibility. “Over the last two years, Cencora has taken significant steps to advance our strategy through investments to further our leadership in specialty and enhance our service to our customers and partners. Our realigned organizational structure reflects our focus on ensuring Cencora is uniquely positioned as a leader in suppo...
-
Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2026 fourth quarter ended September 30, 2026, revenue increased 5.5 percent to $88.4 billion. Revenue increased 5.0 percent to $337.4 billion for fiscal year 2026. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.71 for the fourth quarter of fiscal 2026, compared to $(1.75) in the prior year quarter. Adjusted diluted EPS, which is a no...
-
AdvanSix Announces Third Quarter 2026 Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Announces Third Quarter 2026 Financial Results...
-
TPG Mortgage Investment Trust, Inc. Reports Third Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--TPG Mortgage Investment Trust, Inc. ("MITT," "we," the "Company," or "our") (NYSE: MITT) today reported financial results for the quarter ended September 30, 2026. MANAGEMENT REMARKS “Despite a challenging September, we remained focused on executing our core residential strategies, sponsoring three home equity securitizations and rotating capital into higher-returning residential credit,” said T.J. Durkin, Chief Executive Officer and President. “Looking ahead, we beli...
-
United Therapeutics Corporation Reports Third Quarter 2026 Financial Results
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September 30, 2026. Total revenues in the third quarter of 2026 increased by four percent year-over-year to $832.5 million, compared to $799.5 million in the third quarter of 2025. “United Therapeutics is entering a period of extraordinary growth. We are advancing a portfolio of new therapies...
-
Ralliant Reports Third Quarter 2026 Results and Raises Full Year Guidance
RALEIGH, N.C.--(BUSINESS WIRE)--Ralliant Corporation (“Ralliant” or the “Company”) (NYSE: RAL) today announced financial results for the third quarter of 2026. For the third quarter, revenue of $620 million was up 17% year-over-year on both a total and organic basis. Net earnings were $86 million, and adjusted net earnings were $104 million, resulting in EPS increasing 117% year-over-year to $0.77 and adjusted EPS increasing 64% year-over-year on a normalized basis1 to $0.93. Net earnings margi...